{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:47:04Z","timestamp":1781750824653,"version":"3.54.5"},"reference-count":105,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Meda"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Many current guidelines provide detailed evidence\u2010based recommendations for acne treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To create consensus\u2010based, simple, easy\u2010to\u2010use algorithms for clinical acne treatment in daily office\u2010based practice and to provide checklists to assist in determining why a patient may not have responded to treatment and what action to take.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Existing treatment guidelines and consensus papers were reviewed. The information in them was extracted and simplified according to daily clinical practice needs using a consensus\u2010based approach and based on the authors' clinical expertise.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>As outcomes, separate simple algorithms are presented for the treatment of predominant comedonal, predominant papulopustular and nodular\/conglobate acne. Patients with predominant comedonal acne should initially be treated with a topical retinoid, azelaic acid or salicylic acid. Fixed combination topicals are recommended for patients with predominant papulopustular acne with treatment tailored according to the severity of disease. Treatment recommendations for nodular\/conglobate acne include oral isotretinoin or fixed combinations plus oral antibiotics in men, and these options may be supplemented with oral anti\u2010androgenic hormonal therapy in women. Further decisions regarding treatment responses should be evaluated 8 weeks after treatment initiation in patients with predominant comedonal or papulopustular acne and 12 weeks after in those with nodular\/conglobate acne. Maintenance therapy with a topical retinoid or azelaic acid should be commenced once a patient is clear or almost clear of their acne to prevent the disease from recurring. The principal explanations for lack of treatment response fall into 5 main categories: disease progression, non\u2010drug\u2010related reasons, drug\u2010related reasons, poor adherence, and adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This practical guide provides dermatologists with treatment algorithms adapted to different clinical features of acne which are simple and easy to use in daily clinical practice. The checklists to establish the causes for a lack of treatment response and subsequent action to take will facilitate successful acne management.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.13675","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T07:52:43Z","timestamp":1463212363000},"page":"1480-1490","source":"Crossref","is-referenced-by-count":100,"title":["A consensus\u2010based practical and daily guide for the treatment of acne patients"],"prefix":"10.1111","volume":"30","author":[{"given":"H.P.","family":"Gollnick","sequence":"first","affiliation":[{"name":"Department of Dermatology &amp; Venereology Otto\u2010von\u2010Guericke University Magdeburg Magdeburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bettoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine O.U. of Dermatology Azienda Ospedaliero\u2010Universitaria University of Ferrara Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Antwerp University of Antwerp Edegem Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Araviiskaia","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereal Diseases First I. P. Pavlov State Medical University of St. Petersburg St. Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Binic","sequence":"additional","affiliation":[{"name":"Department of Dermatovenerology Faculty of Medicine University of Nis Nis Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dessinioti","sequence":"additional","affiliation":[{"name":"Department of Dermatology A. Syggros Hospital University of Athens Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Galadari","sequence":"additional","affiliation":[{"name":"School of Medicine United Arab Emirates University Al\u2010Ain United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ganceviciene","sequence":"additional","affiliation":[{"name":"Clinic of Infectious, Chest Diseases, Dermatovenereology and Allergology Vilnius University  Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ilter","sequence":"additional","affiliation":[{"name":"Department of Dermatology Gazi University Medical School Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaegi","sequence":"additional","affiliation":[{"name":"Hautzentrum Z\u00fcrich Z\u00fcrich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kemeny","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University of Szeged Szeged Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"L\u00f3pez\u2010Estebaranz","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Massa","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Dermatol\u00f3gica Dr Ant\u00f3nio Massa Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oprica","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Karolinska Institutet Karolinska University Hospital Huddinge Stockholm Sweden"},{"name":"Diagnostiskt Centrum Hud Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Department of Dermatology Faculty of Health Sciences University of the Free State Bloemfontein South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dr\u00e9no","sequence":"additional","affiliation":[{"name":"Department of Dermato\u2010Cancerology University of Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13462"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2010.04.004"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.019"},{"issue":"5","key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.13186","article-title":"From new findings in acne pathogenesis to new approaches in treatment","volume":"29","author":"Gollnick HP","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04374.x"},{"issue":"1","key":"e_1_2_6_9_1","first-page":"1","article-title":"Acne in India: guidelines for management \u2010 IAA consensus document","volume":"75","author":"Kubba R","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.048"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01266.x"},{"key":"e_1_2_6_12_1","first-page":"1893","article-title":"Guidelines for treatment of acne vulgaris","volume":"118","author":"Hayashi N","year":"2008","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03685.x"},{"key":"e_1_2_6_14_1","first-page":"19","article-title":"The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection","volume":"6","author":"Del Rosso JQ","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.879"},{"key":"e_1_2_6_16_1","first-page":"152","article-title":"A double\u2010blinded, randomized, vehicle\u2010controlled, multicenter, parallel\u2010group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults","volume":"80","author":"Berger R","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.31892"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11597880-000000000-00000"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02190.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.05.2294"},{"key":"e_1_2_6_21_1","first-page":"22","article-title":"Tretinoin: a review of its anti\u2010inflammatory properties in the treatment of acne","volume":"4","author":"Schmidt N","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12823"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/0128071-200809060-00003"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2034.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.597"},{"key":"e_1_2_6_26_1","first-page":"45","article-title":"Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline","volume":"17","author":"Alirezai M","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_27_1","first-page":"268","article-title":"Oral tetracycline and retinoic acid gel in acne","volume":"221","author":"Gould DJ","year":"1978","journal-title":"Practitioner"},{"key":"e_1_2_6_28_1","first-page":"639","article-title":"A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy","volume":"8","author":"Thiboutot DM","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809050-00001"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04276.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.005"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464210-00002"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2309"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12989"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09209.x"},{"key":"e_1_2_6_36_1","first-page":"438","article-title":"The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle\u2010controlled, double\u2010blind studies","volume":"12","author":"Feldman SR","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_37_1","first-page":"20","article-title":"Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports","volume":"57","author":"Graupe K","year":"1996","journal-title":"Cutis"},{"key":"e_1_2_6_38_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1684\/ejd.2014.2293","article-title":"Efficacy and safety of clindamycin phosphate 1.2%\/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double\u2010blind, parallel\u2010group, phase III studies","volume":"24","author":"Dreno B","year":"2014","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_39_1","first-page":"110","article-title":"A North American study of adapalene\u2010benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Gold LS","year":"2009","journal-title":"Cutis"},{"key":"e_1_2_6_40_1","first-page":"4","article-title":"Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris","volume":"14","author":"Tan JK","year":"2009","journal-title":"Skin Therapy Lett"},{"key":"e_1_2_6_41_1","first-page":"16","article-title":"New therapy update\u2013A unique combination formulation in the treatment of inflammatory acne","volume":"72","author":"Fagundes DS","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_42_1","first-page":"13","article-title":"Therapeutic studies with a new combination benzoyl peroxide\/clindamycin topical gel in acne vulgaris","volume":"67","author":"Ellis CN","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_6_43_1","first-page":"1382","article-title":"Safety and efficacy of clindamycin phosphate 1.2%\u2010benzoyl peroxide 3% fixed\u2010dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double\u2010blind, active\u2010 and vehicle\u2010controlled study","volume":"10","author":"Eichenfield LF","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_44_1","first-page":"131","article-title":"A randomized, investigator\u2010blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%\/clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%\/tretinoin 0.025% gel in the topical treatment of acne vulgaris","volume":"9","author":"Jackson JM","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2654"},{"key":"e_1_2_6_46_1","first-page":"103","article-title":"Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial","volume":"86","author":"Yentzer BA","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_6_47_1","first-page":"619","article-title":"A phase IV, open\u2010label study evaluating the use of triple\u2010combination therapy with minocycline HCl extended\u2010release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris","volume":"12","author":"Zaenglein AL","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10374.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2008.07.006"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.03022.x"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051728"},{"key":"e_1_2_6_52_1","first-page":"157","article-title":"The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type","volume":"60","author":"Gollnick H","year":"1999","journal-title":"Ann Endocrinol (Paris)"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607050-00002"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12061"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.05.002"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13681"},{"key":"e_1_2_6_57_1","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft l","year":"2004","journal-title":"Cutis"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70063-5"},{"key":"e_1_2_6_59_1","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle\u2010controlled, double\u2010blind study of adapalene 0.1%\u2010benzoyl peroxide 2.5% fixed\u2010dose combination gel with doxycycline hyclate 100 mg","volume":"85","author":"Gold LS","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_6_60_1","first-page":"37","article-title":"Fixed\u2010dose combination gel of adapalene and benzoyl peroxide plus doxycycline 100 mg versus oral Isotretinoin for the treatment of severe acne: efficacy and cost analysis","volume":"7","author":"Penna P","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13639"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07238.x"},{"key":"e_1_2_6_63_1","first-page":"658","article-title":"A randomized, phase 2, dose\u2010ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium","volume":"12","author":"Leyden JJ","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1159\/000350820"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.03.006"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00890.x"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-11"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.682051"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304040-00005"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2009.08.008"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03937.x"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12966"},{"key":"e_1_2_6_73_1","first-page":"15","article-title":"The role of the vehicle in combination acne therapy","volume":"76","author":"Del Rosso JQ","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_6_74_1","first-page":"281","article-title":"The effect of vehicle formulation on acne medication tolerability","volume":"82","author":"Draelos ZD","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00078.x"},{"key":"e_1_2_6_76_1","first-page":"s53","article-title":"Optimizing acne therapy with unique vehicles","volume":"9","author":"Kircik L","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201694"},{"key":"e_1_2_6_78_1","first-page":"466","article-title":"Evaluating tretinoin formulations in the treatment of acne","volume":"13","author":"Kircik LH","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342140-00005"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(89)90079-X"},{"key":"e_1_2_6_81_1","first-page":"290","article-title":"Clinical inquiries. Which oral antibiotics are best for acne?","volume":"60","author":"Gannon M","year":"2011","journal-title":"J Fam Pract"},{"key":"e_1_2_6_82_1","first-page":"40","article-title":"Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives","volume":"4","author":"Leyden JJ","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.6746"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05409.x"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1983.tb01800.x"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X96326"},{"key":"e_1_2_6_87_1","first-page":"301","article-title":"Not all acne is acne vulgaris","volume":"111","author":"Gollnick HP","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2003.29190.x"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04416.x"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0063-y"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017851"},{"key":"e_1_2_6_92_1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-3-540-69375-8_52","volume-title":"Pathogenesis and Treatment of Acne and Rosacea","author":"Katsambas AD","year":"2014"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07047.x"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.740456"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.481"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.06.001"},{"key":"e_1_2_6_97_1","first-page":"405","article-title":"Clindamycin phosphate 1.2%\u2010 tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability","volume":"81","author":"Del Rosso JQ","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_6_98_1","first-page":"27","article-title":"Microsphere technology: hype or help?","volume":"4","author":"Kircik LH","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_99_1","first-page":"383","article-title":"Tolerability of clindamycin\/tretinoin gel vs. tretinoin microsphere gel and adapalene gel","volume":"8","author":"Leyden J","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_100_1","first-page":"1422","article-title":"A double\u2010blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin\/tretinoin and benzoyl peroxide\/adapalene","volume":"11","author":"Goreshi R","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903277228"},{"key":"e_1_2_6_102_1","first-page":"1654","article-title":"Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study","volume":"28","author":"Lee HE","year":"2014","journal-title":"JEADV"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-009-1832-z"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.2165\/0128071-200910001-00001"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04S1002.x"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb02242.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13675","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:46:18Z","timestamp":1695570378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1111\/jdv.13675"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13675","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}